Antiangiogenic nanotherapy for the control of obesity

Nanomedicine

Volumn 8, Issue 5, 2013, Pages 671-673

  Kajimoto, Kazuaki ^a   Hossen, Nazir ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

active targeting; adipose tissue; angiogenesis; nanoparticle; obesity; passive targeting; vascular endothelial cell

Indexed keywords

AMFEPRAMONE; DEXNORFENFLURAMINE; FENFLURAMINE; METHAMPHETAMINE; NANOPARTICLE; PEPTIDOMIMETIC AGENT; PHENTERMINE; PROAPOPTOTIC PEPTIDE; PROHIBITIN HOMING PEPTIDE; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; DRUG EFFICACY; DRUG TARGETING; HUMAN; NANOTECHNOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANGIOGENESIS INHIBITORS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; OBESITY;

EID: 84877647616     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.27     Document Type: Review

References (20)

1. Melnikova I, Wages D. Anti-obesity therapies. Nat. Rev. Drug Discov. 5(5), 369-370 (2006).
2. Elangbam CS. Review paper: current strategies in the development of anti-obesity drugs and their safety concerns. Vet. Pathol. 46(1), 10-24 (2009).
3. Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4(2), 211-232 (1997).
4. Sierra-Honigmann MR, Nath AK, Murakami C et al. Biological action of leptin as an angiogenic factor. Science 281(5383), 1683-1686 (1998).
5. Rupnick MA, Panigrahy D, Zhang CY et al. Adipose tissue mass can be regulated through the vasculature. Proc. Natl Acad. Sci. USA 99(16), 10730-10735 (2002).
6. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10(6), 625-632 (2004).
7. Ellerby HM, Arap W, Ellerby LM et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5(9), 1032-1038 (1999).
8. Barnhart KF, Christianson DR, Hanley PW et al. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci. Transl. Med. 3(108), 108ra112 (2011).
9. Kim DH, Woods SC, Seeley RJ. Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight. Diabetes 59(4), 907-915 (2010).
10. Staquicini FI, Cardo-Vila M, Kolonin MG et al. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc. Natl Acad. Sci. USA 108(46), 18637-18642 (2011).
11. Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 10(9), 3223-3230 (2010).
12. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46(12 Pt 1), 6387-6392 (1986).
13. Hossen MN, Kajimoto K, Akita H, Hyodo M, Ishitsuka T, Harashima H. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J. Control. Release 147(2), 261-268 (2010).
14. Kajimoto K, Hossen MN, Hida K et al. Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues. J. Immunol. Methods 357(1-2), 43-50 (2010).
15. Hossen MN, Kajimoto K, Akita H, Hyodo M, Harashima H. Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. J. Control. Release 163(2), 101-110 (2012).
16. Nishimura S, Manabe I, Nagasaki M et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56(6), 1517-1526 (2007).
17. Nishimura S, Manabe I, Nagasaki M et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J. Clin. Invest. 118(2), 710-721 (2008).
18. Karjalainen K, Jaalouk DE, Bueso-Ramos CE et al. Targeting neuropilin-1 in human leukemia and lymphoma. Blood 117(3), 920-927 (2011).
19. Kunitomo R, Miyauchi Y, Inoue M. Synthesis of a cytochrome C derivative with prolonged in vivo half-life and determination of ascorbyl radicals in the circulation of the rat. J. Biol. Chem. 267(13), 8732-8738 (1992).
20. Hossen MN, Kajimoto K, Akita H, Hyodo M, Ishitsuka T, Harashima H. Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system. Mol. Ther. 21(3), 533-541 (2013).